Trials / Completed
CompletedNCT00663481
A Clinical Trial of CoFactor Formulations and Leucovorin Administered Intravenously in Healthy, Adult Subjects.
A Single Dose, Within Subject, 3 Period, Pharmacokinetic Bridging Study of CoFactor Formulations and of Leucovorin Administered Intravenously in Healthy, Adult Subjects.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Mast Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the safety and tolerability of CoFactor in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CoFactor | |
| DRUG | Leucovorin |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2008-05-01
- Completion
- 2008-05-01
- First posted
- 2008-04-22
- Last updated
- 2009-05-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00663481. Inclusion in this directory is not an endorsement.